Ian George Tucker

Title: Ian George Tucker: Innovator in Controlled Release Compositions and Injectable Formulations

Introduction

Ian George Tucker, a prominent inventor based in Hamilton, New Zealand, has made significant contributions in the pharmaceutical field. With two patents to his name, Tucker's innovations focus on controlled release compositions and injectable antibiotic formulations. His work has the potential to enhance drug delivery systems, improving patient outcomes and therapeutic efficacy.

Latest Patents

Tucker's most recent patents include:

1. **Controlled Release Compositions and Their Methods of Use** - This invention relates to a composition comprising a therapeutically effective amount of at least one active agent, along with a base that includes colloidal silica, at least one oil, and at least one surfactant. Notably, the viscosity of the composition is below 1000 mPas at a shear rate of 100 l/s at a temperature of 20°C.

2. **Injectable Antibiotic Formulations and Their Methods of Use** - This invention is focused on a composition that includes penethamate (PNT) or a pharmaceutical equivalent and at least one oily vehicle. This formulation aims to improve the administration of antibiotics.

Career Highlights

Throughout his career, Ian George Tucker has worked with prestigious companies such as Bayer New Zealand Limited and Otago Innovation Limited. His employment in these organizations has provided him with a solid foundation in research and development, leading to his valuable patent contributions in the industry.

Collaborations

Tucker has collaborated with notable professionals, including Fadil Al Alawi and Olaf Bork. These partnerships have facilitated the exchange of ideas and expertise, enriching the development of his innovative patents.

Conclusion

Ian George Tucker stands out as an inventive force in the realm of pharmaceuticals. His patents not only reflect his dedication to advancing drug delivery methods but also underscore the importance of innovation in healthcare. As the pharmaceutical industry continues to evolve, contributions like those of Tucker will remain essential in addressing the challenges of effective treatment options.